By clicking “Accept,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
As of November 2026, the FDA has extended exemptions from certain enhanced DSCSA requirements for qualifying small dispensers and, where applicable, their trading partners through November 27, 2027.
For purposes of this exemption, the FDA defines a small dispenser as a company that owns a dispenser and has 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians as of November 27, 2026. Qualifying small dispensers don’t need to submit anything to the FDA or notify the agency to use the exemption.
The additional time doesn’t mean pharmacies should pause their compliance efforts. The FDA continues to urge small dispensers to implement the systems, workflows, training, and trading-partner coordination needed to meet the enhanced drug-distribution security requirements.
Learn what you need to know about DSCSA compliance for pharmacies.
The Drug Quality and Security Act (DQSA) was passed on November 27, 2013. Title 2 of the DQSA, the Drug Supply Chain Security Act (DSCSA) presents steps to “achieve interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States.”
The DSCSA helps protect patients from exposure to counterfeit, contaminated, stolen, or harmful medications.
Most DSCSA compliance requirements are already in place. The November 27, 2023 (which is also the 10th anniversary of the DQSA’s passing) deadline was the second phase of DSCSA, which launched the Track and Trace serialization law.
InfiniTrak President Mark Tate goes over the basics of DSCSA compliance on the Catalyst Pharmacy Podcast. Tune in here:
Most of the aspects of DSCSA are already in place. Learn more about these requirements to see if your pharmacy is compliant.

As of November 2026, here are the current DSCSA requirements and implementation priorities independent pharmacies should understand.
The main focus of DSCSA compliance is between your pharmacy and your drug suppliers. Licensure verification is required for all drug suppliers, no matter how often or rarely you use them.
Likewise, do not rely on drug suppliers or manufacturers to cover your DSCSA-related bases. This is all about making sure your pharmacy stays DSCSA compliant. When it comes to compliance between your pharmacy and drug suppliers, you can’t have one without the other.
A common practice in independent pharmacies, selling or lending products to another pharmacy now has to be done within DSCSA guidelines.
If your pharmacy is the one selling or lending products to another pharmacy, you must provide complete and accurate transaction data with the drug. It might seem tedious at first but will make DSCSA compliance easier in the long run.
Continuing with your relationship with drug suppliers, make sure their electronic data is complete, accurate, and stored for six years.
DSCSA compliance is ensuring your pharmacy can detect any counterfeit or harmful medications before they reach your patient.
Your pharmacy must have Standard Operating Procedures (SOPs) to identify suspect or illegitimate products. Make sure you document the process, which should always consist of notifying the FDA and drug supplier of the counterfeit product.
This is a brief rundown of what your pharmacy should already be doing within DSCSA compliance. Now let’s look at the enhanced requirements qualifying small dispensers should prepare to meet when the exemption period ends on November 27, 2027.
While implementation deadlines have passed for several other trading-partner categories, qualifying small dispensers have received an additional exemption from certain enhanced DSCSA requirements through November 27, 2027. The exemption doesn’t suspend every DSCSA obligation, so pharmacies should continue following the requirements already in effect.
Use this additional time to evaluate your technology, review data-exchange processes, train employees, document standard operating procedures, and coordinate with wholesalers and other trading partners. Before November 27, 2027, make sure your pharmacy is making progress in the following areas:

Chances are your pharmacy receives data through an EDI (electronic data interchange) format. DSCSA compliance requires you to move over to the EPCIS (Electronic Product Code Information Services) format.
As a result of this requirement, EDI data will no longer be a part of DSCSA compliance.
Per the FDA, “EPCIS is an appropriate globally recognized standard, and [...] there is considerable agreement among stakeholders that EPCIS is a suitable standard to adopt for the enhanced drug distribution security requirements".

Most pharmacists already receive their shipments this way, but things might look different for fill facilities or larger pharmacies.
DSCSA compliance requires you to manually enter and scan products at intake. You also must confirm all products have a product identifier, such as a 2D Barcode.
PioneerRx’s 2D Barcode scanning feature makes this part of DSCSA compliance simple.
RedSail Technologies’ Director of Education and Training Erin Dalton talks about the importance of this aspect of DSCSA compliance:
“2D barcode scanning allows pharmacies to capture product information and identify any inconsistencies from any electronic files sent by trading partners. This lets pharmacists quickly remove said products from the supply chain for suspected counterfeiting.”
Under the enhanced DSCSA requirements, a dispenser can request the status of a certain drug, requiring the manufacturer to respond electronically on the status of the product in question within 24 hours.
As with nearly all aspects of DSCSA compliance, have a plan in place to handle product verification requests. It could affect your pharmacy’s workflow when you or a manufacturer have to present the product information within a tight time window.
DSCSA compliance requires reliable workflows for scanning, documentation, product tracing, supplier coordination, and handling suspect or illegitimate products. PioneerRx helps support these efforts with tools that fit into the daily dispensing process, including 2D barcode scanning that can help capture important product details like lot information.
PioneerRx also connects pharmacies with DSCSA-focused vendor solutions designed to support dispenser compliance. Through connected vendors like InfiniTrak and LSPedia, pharmacies can access tools for track-and-trace requirements, EPCIS data management, trading partner verification, audit readiness, and other DSCSA-related workflows.
DSCSA compliance is shaping the future of pharmacy in the United States. Chains and independent pharmacies alike must adjust their workflow accordingly to ensure they are DSCSA compliant.
Just like pharmacy work, staying compliant is a continuous process. There’s always something new to learn.
Sam Pizzo and Mark Tate of InfiniTrak came on the Catalyst Pharmacy Podcast to discuss the ins and outs of DSCSA compliance. Tune in to learn more about what you need to know about DSCSA compliance.
Erin Dalton and Mark Tate held a webinar regarding DSCSA compliance and InfiniTrak’s role in helping your pharmacy stay compliant. Go to PioneerRx University to catch recordings of both the webinar and Q&A.
Because DSCSA requirements and exemptions can change, consult the FDA’s DSCSA exemptions page for the latest agency guidance and deadlines.
We want to hear from you! Take our brief survey to share what solutions you’re looking for next. Take the survey!